Arthroscopic debridement, and / or lavage, has been shown to have no beneficial effect on the natural history of osteoarthritis, nor is it indicated as a primary treatment in the management of osteoarthritis. However, this does not preclude the judicious use of arthroscopic surgery, when indicated, to manage symptomatic coexisting pathology, in the presence of osteoarthritis or degeneration. Partial medial meniscectomy is not indicated as an initial treatment for atraumatic tears of degenerative menisci, excluding bucket handle tears and surgeon assessed locked or locking knees.
A detailed history and examination, followed by a standardised series of plain radiographs where indicated, remains the cornerstone methodology to the clinical diagnosis of knee osteoarthritis.
The Australian Knee Society (AKS) is concerned about the increasing use of the LARS device for anterior cruciate ligament reconstruction in the absence of sufficient evidence to support its widespread use.
In a 2011 survey of members of the AKS the majority considered that this device does not heal to bone, may cause articular surface damage (with possible premature arthritis), and will fail as have other synthetic ligaments.
The view of the AKS is that the use of the LARS device should be limited to those surgeons who follow specific indications and will follow up and report their results to an appropriate meeting of their peers such as the AKS or Australian Orthopaedic Association.
In 2010 the AKS was consulted to provide guidance to the Australian Orthopaedic Association on what advice it may give, if asked by any of its members, or members of the public, any questions regarding the burgeoning use of the LARS device for ACL reconstructive surgery. A survey of AKS members was conducted in December 2010. As a result of that survey, a consensus position statement was developed in March 2011.